| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |